☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
teva
Teva and mAbxience Join Forces on Second Biosimilar Candidate in Oncology
October 4, 2024
Insights+ Key Biosimilars Events of May 2024
June 4, 2024
Teva and Alvotech Launches Simlandi (Biosimilar, Humira) Injection Across US to Treat Multiple Indications
May 20, 2024
Teva and Alvotech’s Selarsdi (Biosimilar, Stelara) Receives the US FDA’s Approval
April 17, 2024
Teva Presents P-IV (UNITE) Study Results of Ajovy (fremanezumab) for Migraine and Major Depressive Disorder at World Congress of N...
October 17, 2023
Insights+: The US FDA New Drug Approvals in May 2023
June 22, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.